- Trials with a EudraCT protocol (70)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
70 result(s) found for: Insomnia AND Sleep Disorders.
Displaying page 1 of 4.
EudraCT Number: 2016-000827-16 | Sponsor Protocol Number: AC-078A202 | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, double-blind, randomized, placebo-controlled, 5-period, 5-treatment crossover, polysomnography dose-response study to assess the efficacy and safety of ACT-541468 in elderly subjects ... | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004259-59 | Sponsor Protocol Number: AC-078A203 | Start Date*: 2017-01-31 | |||||||||||
Sponsor Name:Idorsia Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, single-arm, open-label study in patients with Insomnia Disorder to validate the Insomnia Daytime Symptoms and Impacts Questionnaire™ (IDSIQ™) | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004643-20 | Sponsor Protocol Number: ID-078A302 | Start Date*: 2018-06-18 | |||||||||||
Sponsor Name:Idorsia Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography study to assess the efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) FI (Completed) DE (Completed) SE (Completed) FR (Completed) CZ (Completed) BE (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005303-34 | Sponsor Protocol Number: EFC6072 | Start Date*: 2007-06-01 |
Sponsor Name:sanofi-aventis recherche & développement | ||
Full Title: Efficacy and safety of 2 mg/day M100907 on Sleep Maintenance Insomnia: a 6-week, multicenter, randomized, double-blind, placebo-controlled Polysomnographic study | ||
Medical condition: Sleep maintenance insomnia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) FR (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004942-18 | Sponsor Protocol Number: LTE6673 | Start Date*: 2007-03-14 | |||||||||||
Sponsor Name:sanofi-aventis recherche et developpment | |||||||||||||
Full Title: Efficacy and safety of 2 mg/day of M100907 on Sleep Maintenance Insomnia with a sub-study of the effect of M100907 on stable Type II Diabetes Mellitus: a One Year, multi-center, randomized, double-... | |||||||||||||
Medical condition: sleep maintenance insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) IT (Prematurely Ended) DE (Prematurely Ended) BE (Completed) ES (Completed) AT (Prematurely Ended) GR (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005194-56 | Sponsor Protocol Number: AC-057A301 | Start Date*: 2008-07-06 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi center, double blind, randomized, placebo controlled, active reference, parallel group polysomnography study to assess the efficacy and safety of a 16 day oral administration of ACT 078573 in... | |||||||||||||
Medical condition: Chronic primary insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) AT (Completed) HU (Completed) SK (Completed) DE (Completed) FI (Completed) ES (Completed) CZ (Completed) FR (Completed) DK (Completed) GB (Completed) IT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003766-27 | Sponsor Protocol Number: 848015011 | Start Date*: 2018-07-18 | |||||||||||
Sponsor Name:VU University Medical Centre | |||||||||||||
Full Title: The DREAMING study: Efficacy of low dose amitriptyline and mirtazapine for insomnia disorder: a double-blind, randomized, placebo-controlled trial in general practice | |||||||||||||
Medical condition: Insonnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003154-40 | Sponsor Protocol Number: MK-4305-061 | Start Date*: 2017-01-11 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Subjects with Alzheimer’s Disease | |||||||||||||
Medical condition: Insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000037-36 | Sponsor Protocol Number: KLF/K/010710 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:MCM Klosterfrau GmbH & Co. KG | |||||||||||||
Full Title: Open label clinical trial to investigate the physiological effects on sleep of Nervenruh Baldrian Forte 600 in patients with primary insomnia | |||||||||||||
Medical condition: Primary (psychophysiologic) insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002711-25 | Sponsor Protocol Number: 039SC04253 | Start Date*: 2005-08-01 | |||||||||||
Sponsor Name:ANGELINI | |||||||||||||
Full Title: DOSE-FINDING STUDY OF TRAZODONE IN THE TREATMENT OF PATIENTS WITH PRIMARY INSOMNIA | |||||||||||||
Medical condition: TREATMENT OF THE INSOMNIA | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) SK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001688-31 | Sponsor Protocol Number: 604296B | Start Date*: 2007-06-04 | |||||||||||
Sponsor Name:Larime company of the Mediscis group | |||||||||||||
Full Title: Monitoring des états cognitifs chez des sujets volontaires sains, sur 2 périodes, l'une avant et après administration d'une dose unique de Zolpidem, l'autre sans administration de traitement | |||||||||||||
Medical condition: It's a phase II study performed on healthy volonteers. Zolpidem (DCI) will be administered to the volunteers in order to inducing a drowsiness and a hypoattentiveness. Zolpidem is indicated in the ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004642-20 | Sponsor Protocol Number: ID-078A301 | Start Date*: 2018-07-02 | |||||||||||
Sponsor Name:Idorsia Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography study to assess the efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001966-87 | Sponsor Protocol Number: FCD-LOR-1402 | Start Date*: 2015-07-30 | |||||||||||
Sponsor Name:FERRER INTERNACIONAL, S.A. | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled cross-over dose finding study of two doses of lorediplon in adult patients with insomnia disorder | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000826-21 | Sponsor Protocol Number: AC-078A201 | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, double-blind, randomized, placebo-controlled, active reference, parallel-group, polysomnography dose response study to assess the efficacy and safety of ACT-541468 in adult subjects w... | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) HU (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000980-33 | Sponsor Protocol Number: 42847922ISM2005 | Start Date*: 2018-06-11 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Active- and Placebo-Controlled Polysomnography Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Subjects with Ins... | |||||||||||||
Medical condition: Insomnia Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) PL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005236-92 | Sponsor Protocol Number: 21106 | Start Date*: 2008-04-22 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A 6-month, double-blind, randomized, placebo-controlled, parallel group outpatient trial, investigating the efficacy and safety of Org 50081 in adult patients with chronic primary insomnia. | |||||||||||||
Medical condition: Primary insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) HU (Prematurely Ended) SE (Completed) NL (Completed) DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000691-94 | Sponsor Protocol Number: CHUBX2014/35 | Start Date*: 2016-01-29 | |||||||||||||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||||||||||||
Full Title: Self-help program for hypnotics withdrawal in insomniac patients: A randomized controlled clinical trial. | |||||||||||||||||||||||
Medical condition: Insomnia Chronic hypnotic users | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001463-39 | Sponsor Protocol Number: E2006-G000-303 | Start Date*: 2017-04-04 | |||||||||||
Sponsor Name:Eisai Ltd. | |||||||||||||
Full Title: A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel-Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder | |||||||||||||
Medical condition: Treatment for insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004644-38 | Sponsor Protocol Number: ID-078A303 | Start Date*: 2018-10-30 | |||||||||||
Sponsor Name:Idorsia Pharmaceuticals Ltd | |||||||||||||
Full Title: Multi-center, double-blind, parallel-group, randomized, placebo-controlled, three doses, 40-week extension to studies ID-078A301 and ID-078A302 to assess the long term safety and tolerability of AC... | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) FI (Completed) SE (Completed) DE (Completed) CZ (Completed) FR (Completed) HU (Completed) ES (Completed) BG (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002523-33 | Sponsor Protocol Number: 21108 | Start Date*: 2007-10-31 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A double-blind, randomized, parallel group, placebo-controlled sleep laboratory efficacy and safety study with Org 50081 in elderly subjects with chronic primary insomnia | |||||||||||||
Medical condition: Primary insomnia | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) DK (Completed) GB (Completed) HU (Completed) CZ (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.